Mid
U
URGNAI Stock Diagnostic Report
UroGen to invest up to $7M in IntraGel as part of an option agreement
UroGen Pharma has agreed to invest up to $7 million in IntraGel Therapeutics as part of an oncology field option agreement.
View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
URGN Analysis History (Last 30 Days)